WHIP 131Alternative Names: DDE 9501; WHI P131
Latest Information Update: 10 Sep 2003
At a glance
- Originator Wayne Hughes Institute
- Class Anti-inflammatories
- Mechanism of Action Apoptosis stimulants; Collagen inhibitors; Janus kinase 3 inhibitors; Mast cell inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Allergic asthma; Amyotrophic lateral sclerosis; Cancer; Graft-versus-host disease; Skin disorders; Thromboembolism; Thrombosis